Quintiles and Kaiser Permanente Announce Alliance to Accelerate Drug Development
Quintiles announced an agreement to help accelerate the development of new and more effective medicines. Southern California Permanente Medical Group will join Quintiles’ three other prime sites globally, selected for their long-term commitment to clinical research.
Clinical research professionals from both Quintiles and SCPMG will work together closely to enhance the productivity and quality of clinical research offered at the SCPMG site.
Donald S. Fong, MD, MPH, Director of Clinical Trials, SCPMG Department of Research & Evaluation, Kaiser Permanente Southern California says, “The Southern California Permanente Clinical Trials program works on the premise that all clinical trials research should focus on advancing the practice of medical care to improve health outcomes through rigorously designed and executed trials.
“Southern California Permanente Clinical Trial investigators are practicing physicians who use their clinical acumen and methodological training to bridge the gap between basic research and clinical practice. Typically, clinical trials research in Kaiser Permanente is aimed at evaluating the impact of interventions at the bedside. This perspective ensures that trials address meaningful questions.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
